JP2016533391A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533391A5
JP2016533391A5 JP2016545246A JP2016545246A JP2016533391A5 JP 2016533391 A5 JP2016533391 A5 JP 2016533391A5 JP 2016545246 A JP2016545246 A JP 2016545246A JP 2016545246 A JP2016545246 A JP 2016545246A JP 2016533391 A5 JP2016533391 A5 JP 2016533391A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
salt
compound
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533391A (ja
JP6794258B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057876 external-priority patent/WO2015048558A1/en
Publication of JP2016533391A publication Critical patent/JP2016533391A/ja
Publication of JP2016533391A5 publication Critical patent/JP2016533391A5/ja
Application granted granted Critical
Publication of JP6794258B2 publication Critical patent/JP6794258B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545246A 2013-09-30 2014-09-26 オリゴヌクレオチドについてのホスホロジアミデート骨格結合 Active JP6794258B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361884848P 2013-09-30 2013-09-30
US61/884,848 2013-09-30
PCT/US2014/057876 WO2015048558A1 (en) 2013-09-30 2014-09-26 Phosphorodiamidate backbone linkage for oligonucleotides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019017856A Division JP2019065054A (ja) 2013-09-30 2019-02-04 オリゴヌクレオチドについてのホスホロジアミデート骨格結合

Publications (3)

Publication Number Publication Date
JP2016533391A JP2016533391A (ja) 2016-10-27
JP2016533391A5 true JP2016533391A5 (enExample) 2017-11-24
JP6794258B2 JP6794258B2 (ja) 2020-12-02

Family

ID=52744544

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016545246A Active JP6794258B2 (ja) 2013-09-30 2014-09-26 オリゴヌクレオチドについてのホスホロジアミデート骨格結合
JP2019017856A Pending JP2019065054A (ja) 2013-09-30 2019-02-04 オリゴヌクレオチドについてのホスホロジアミデート骨格結合

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019017856A Pending JP2019065054A (ja) 2013-09-30 2019-02-04 オリゴヌクレオチドについてのホスホロジアミデート骨格結合

Country Status (5)

Country Link
US (2) US9708360B2 (enExample)
EP (2) EP3868772A1 (enExample)
JP (2) JP6794258B2 (enExample)
CA (1) CA2925500C (enExample)
WO (1) WO2015048558A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3868772A1 (en) * 2013-09-30 2021-08-25 Geron Corporation Phosphorodiamidate backbone linkage for oligonucleotides
CN109160931A (zh) * 2017-08-17 2019-01-08 王秀香 一种1/2水胞磷胆碱钠化合物
WO2020086311A1 (en) * 2018-10-23 2020-04-30 The Regents Of The University Of California Thiophosphorodichloridate reagents for chemoselective histidine bioconjugation
US20240173231A1 (en) * 2021-03-16 2024-05-30 Conopco, Inc., D/B/A Unilever Cosmetic skin care composition

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
NZ209840A (en) 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
US5550111A (en) 1984-07-11 1996-08-27 Temple University-Of The Commonwealth System Of Higher Education Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US5521063A (en) 1985-03-15 1996-05-28 Antivirals Inc. Polynucleotide reagent containing chiral subunits and methods of use
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US5185444A (en) 1985-03-15 1993-02-09 Anti-Gene Deveopment Group Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5217866A (en) 1985-03-15 1993-06-08 Anti-Gene Development Group Polynucleotide assay reagent and method
WO1986005519A1 (en) 1985-03-15 1986-09-25 James Summerton Polynucleotide assay reagent and method
US5166315A (en) 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US4806463A (en) 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5194428A (en) 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5264423A (en) 1987-03-25 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5276019A (en) 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5188897A (en) 1987-10-22 1993-02-23 Temple University Of The Commonwealth System Of Higher Education Encapsulated 2',5'-phosphorothioate oligoadenylates
US4924624A (en) 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
WO1989009221A1 (en) 1988-03-25 1989-10-05 University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
US5278302A (en) 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
US5194599A (en) 1988-09-23 1993-03-16 Gilead Sciences, Inc. Hydrogen phosphonodithioate compositions
US5004810A (en) 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers
US5098890A (en) 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
US5087617A (en) 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5399676A (en) 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
US5721218A (en) 1989-10-23 1998-02-24 Gilead Sciences, Inc. Oligonucleotides with inverted polarity
US5177198A (en) 1989-11-30 1993-01-05 University Of N.C. At Chapel Hill Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
US5587361A (en) 1991-10-15 1996-12-24 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5321131A (en) 1990-03-08 1994-06-14 Hybridon, Inc. Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling
US5470967A (en) 1990-04-10 1995-11-28 The Dupont Merck Pharmaceutical Company Oligonucleotide analogs with sulfamate linkages
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
US5135917A (en) 1990-07-12 1992-08-04 Nova Pharmaceutical Corporation Interleukin receptor expression inhibiting antisense oligonucleotides
US5177196A (en) 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
US5672697A (en) 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5242906A (en) 1991-04-22 1993-09-07 University Of North Carolina At Chapel Hill Antisense oligonucleotides against Epstein-Barr virus
US5571799A (en) 1991-08-12 1996-11-05 Basco, Ltd. (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
US6033909A (en) 1992-01-22 2000-03-07 Hoechst Aktiengesellschaft Oligonucleotide analogs, their preparation and use
US5629154A (en) 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
US5837453A (en) 1992-05-13 1998-11-17 Geron Corporation Telomerase activity assays
US5476925A (en) 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
GB9304618D0 (en) 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
US5863726A (en) 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
US5726297A (en) 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
US5625050A (en) 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
DE4415370A1 (de) 1994-05-02 1995-11-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US5859233A (en) 1996-02-21 1999-01-12 Lynx Therapeutics, Inc. Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates
US5684143A (en) * 1996-02-21 1997-11-04 Lynx Therapeutics, Inc. Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates
WO1997037691A1 (en) * 1996-04-10 1997-10-16 Lynx Therapeutics, Inc. Telomerase inhibitors
DE19627898A1 (de) 1996-07-11 1998-01-15 Hoechst Ag Festphasensynthese von Oligonucleotiden
AU733610B2 (en) 1996-12-20 2001-05-17 Geron Corporation Methods for detecting and inhibiting the RNA component of telomerase
US6191120B1 (en) * 1998-03-25 2001-02-20 Wayne Hughes Institute Spermicidally active 5-halo-6-alkoxy-5,6-dihydro-2′,3′-dideoxy-uridines and their pharamaceutical compositions
US6482805B2 (en) * 1998-03-25 2002-11-19 Parker Hughes Institute AZT derivatives exhibiting spermicidal and anti-viral activity
AU767646B2 (en) 1999-09-10 2003-11-20 Geron Corporation Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use
US7321029B2 (en) 2000-01-21 2008-01-22 Geron Corporation 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
EP1379689B1 (en) * 2001-03-23 2012-09-26 Geron Corporation Oligonucleotide conjugates
WO2003073989A2 (en) 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
SI3342425T1 (sl) 2003-09-09 2020-04-30 Geron Corporation Modificirani oligonukleotidi za inhibicijo telomeraze
ATE503014T1 (de) 2003-11-04 2011-04-15 Geron Corp Rna-amidate und thioamidateur rnai
CN100558739C (zh) 2004-07-02 2009-11-11 杰龙公司 合成被保护的3’-氨基核苷单体
WO2006113470A2 (en) * 2005-04-15 2006-10-26 Geron Corporation Cancer treatment by combined inhibition of proteasome and telomerase activities
WO2007127163A2 (en) * 2006-04-24 2007-11-08 Geron Corporation Cns-tumor treatment method and composition
US8785409B2 (en) * 2007-01-30 2014-07-22 Geron Corporation Compounds having anti-adhesive effects on cancer cells
DK2207779T3 (da) 2007-11-15 2014-07-14 Sarepta Therapeutics Inc Fremgangsmåde til syntese af morpholinooligomerer
EP3868772A1 (en) * 2013-09-30 2021-08-25 Geron Corporation Phosphorodiamidate backbone linkage for oligonucleotides

Similar Documents

Publication Publication Date Title
US9169256B2 (en) Artificial nucleic acids
EP0719272B1 (en) Pyrimidine derivatives for labeled binding partners
JP2021512629A5 (enExample)
FI3794012T3 (fi) Koostumuksia ja menetelmiä pintaan sitoutuneiden oligonukleotidien kemiallista pilkkomista ja suojauksen poistoa varten
JP2018088924A5 (enExample)
RU2016107198A (ru) Аналоги нуклеотидов
JP2016512206A5 (enExample)
JP2016530294A5 (enExample)
RU2015126856A (ru) Дисульфидные маскированные пролекарственные композиции и способы
JP2023546369A5 (enExample)
EP3943500A1 (en) Phosphorous protecting groups and methods of preparation and use thereof
JP2017514479A5 (enExample)
JP2019529406A5 (enExample)
JP2020525502A5 (enExample)
JPWO2018052063A1 (ja) ヌクレオシド誘導体またはその塩、ポリヌクレオチドの合成試薬、ポリヌクレオチドの製造方法、ポリヌクレオチド、および結合核酸分子の製造方法
ES2586599T3 (es) Ensayo para cribar compuestos que disminuyen selectivamente el número de células madre de cáncer
WO2016034735A1 (en) Chemo-enzymatic preparation method for purine nucleosides and their deaza- and aza- analogues
JP2021530993A5 (enExample)
RU2019143004A (ru) Антисмысловые олигонуклеотиды для модулирования экспрессии htra1
Eritja Solid-phase synthesis of modified oligonucleotides
WO2003051897A1 (en) Nucleoside analog libraries and compounds
US20120108533A1 (en) Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
US11542294B2 (en) Rapid unylinker cleavage
Reddy et al. Solid-phase synthesis of positively charged deoxynucleic guanidine (DNG) oligonucleotide mixed sequences
JP2019522058A5 (enExample)